Advertisement
Loading...

Hua Medicine (Shanghai) Ltd.

HUMDFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.43
$0.00(0.00%)
U.S. Market is Open • 14:09
Advertisement

Hua Medicine (Shanghai) Ltd. (HUMDF) Stock Competitors & Peer Comparison

See (HUMDF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HUMDF$0.43+0.00%430.9M2.70$0.16N/A
MKGAF$153.71+1.05%67.7B22.97$6.78+1.65%
MKKGY$30.38+1.03%65.9B22.13$1.37+1.70%
IPSEY$46.60-0.72%61.6B30.26$1.54+0.86%
TKPHF$32.10-1.53%50.7B42.80$0.75+4.06%
HLNCF$4.80+3.90%42.5B19.20$0.25+1.99%
SDZNY$83.38+1.70%36B39.80$2.09+1.23%
TEVJF$30.19+0.00%35.2B24.95$1.21N/A
TAIPY$14.00+16.67%18.1B82.35$0.17N/A
ESALY$61.51-2.11%17.6B20.54$3.00N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HUMDF vs MKGAF Comparison May 2026

HUMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HUMDF stands at 430.9M. In comparison, MKGAF has a market cap of 67.7B. Regarding current trading prices, HUMDF is priced at $0.43, while MKGAF trades at $153.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HUMDF currently has a P/E ratio of 2.70, whereas MKGAF's P/E ratio is 22.97. In terms of profitability, HUMDF's ROE is +1.07%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, HUMDF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for HUMDF.Check MKGAF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions